Netherlands· NL-fef8a8a2ab92
Holoclar, levend weefsel equivalent
A limbale stammzellen, autolog product containing ex-vivo geëxpandeerd autoloog humaan corneaal epitheel dat stamcellen bevat, suspensie van keratinocyten, registered in Netherlands by Holostem s.r.l.. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Limbale stammzellen, autolog is registered in 8 of 19 countries.
Countries holding a registration under ATC S01XA19 (limbale stammzellen, autolog), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Limbale stammzellen, autolog · ATC S01XA19
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- EX-VIVO GEËXPANDEERD AUTOLOOG HUMAAN CORNEAAL EPITHEEL DAT STAMCELLEN BEVAT, SUSPENSIE VAN KERATINOCYTEN
- Manufacturer
- Holostem s.r.l.
- Country
- Netherlands (NL)
- ATC code
- S01XA19
- ATC class
- Limbale Stammzellen, autolog
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/14/987
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01XA19
Limbale stammzellen, autolog, as other registers publish it.
- DenmarkHoloclarHolostem Terapie Avanzate S.r.l.
- PolandHoloclarHolostem s.r.l.
- FinlandHoloclarHolostem s.r.l
- IcelandHoloclarHolostem S.r.l.
- CzechiaHOLOCLARHolostem s.r.l., Modena
- IrelandHoloclar 79,000 - 316,000 cells/cm2 living tissue equivalentHolostem S.r.l.
- BelgiumHoloclar 79000 cells/cm² - 316000 cells/cm²Holostem
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a5e0819-164b-42f0-bb6f-bfa147f02630 GET /v1/drugs/2a5e0819-164b-42f0-bb6f-bfa147f02630?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Levend weefsel equivalent",
"route": "Implantatie",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/holoclar-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Limbal stems cells, autologous",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113652",
"excipients": [
"DULBECCO'S GEMODIFICEERD EAGLES MEDIUM",
"FIBRINE ONDERSTEUNENDE LAAG VOOR CEL SUSPENSIE",
"GLUTAMINE, (L-)"
],
"substances": [
"EX-VIVO GEËXPANDEERD AUTOLOOG HUMAAN CORNEAAL EPITHEEL DAT STAMCELLEN BEVAT, SUSPENSIE VAN KERATINOCYTEN"
],
"leaflet_url": null,
"authorised_at": "2015/02/19",
"procedure_number": "EMEA/H/C/002450",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/14/987",
"additional_monitoring": "Y"
}See everything about limbale stammzellen, autolog.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.